CD96 and neoplasm: To clarify the functional significance of sCD155 in tumor immunity, further studies are required how the interaction of sCD155 with its activating (DNAM-1) and inhibitory (CD96 and TIGIT) receptors and their signaling via these activating and inhibitory receptors are regulated.